Cadila Pharmaceuticals launches Dlorfast-M tablets for management of allergic rhinitis and urticaria
The new fixed-dose combination of Desloratadine and Montelukast aims to support patients with respiratory and skin-related…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Cadila Pharmaceuticals
Cadila Pharmaceuticals launches Nu Nutridac capsule for anxiety-related disorders
Cadila Pharmaceuticals, one of India’s research-driven pharmaceutical companies, has launched Nu Nutridac, a clinically proven…
Cadila Pharmaceuticals launches Bilacad Dex Syrup
Bilacad Dex Syrup is a triple-action formula for comprehensive respiratory relief
Cadila Pharmaceuticals launches Empadon (Empagliflozin)
Clinical trials have consistently shown empagliflozin’s efficacy in reducing cardiovascular mortality, heart failure…
Panel Discussion: Next-gen Pharma Innovation
The first panel discussion at Ahmedabad Pharma Summit 2025 was on ‘Next-gen Pharma Innovation.’ The session delved into the…
Cadila Pharmaceuticals marks three years of ThRabis, a three-dose rabies vaccine
ThRabis rollout sees increased vaccine compliance and reduced treatment burden across multiple regions
Cadila Pharmaceuticals launches Vasograin EC with US FDA-approved formulation for migraine relief
Reformulated Vasograin EC manufactured in USFDA-approved facility; retains leading position in ergotamine segment
Cadila Pharma launches Cadilose, a lactulose solution for constipation and hepatic encephalopathy
Cadilose is a disaccharide-based osmotic laxative, synthesised from galactose and fructose, which increases water retention in the…
Cadila Pharmaceuticals expands warehouse to strengthen logistics and market reach
Cadila Pharmaceuticals expands its warehouse facility to enhance operational efficiency, streamline logistics, and support growing…
Cadila Pharmaceuticals launches iron supplement ‘Militol’
Militol’s supplements contain ferric maltol, a low-dose form of ferric iron complexed with maltol and folic acid